China Pharma Holdings, Inc. (CPHI)

NYSEAMERICAN: CPHI · Real-Time Price · USD

1.110

-0.190 (-14.62%)

At close: Jul 31, 2026, 4:00 PM EDT

1.125

+0.015 (1.35%)

Pre-market: Aug 3, 2026, 4:24 AM EDT

China Pharma Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.17	0.35	0.63	1.42	2.03	4.86
Short-Term Investments	-	-	0.02	0.07	0.01	0.09
Cash & Short-Term Investments	0.17	0.35	0.65	1.49	2.04	4.95
Cash Growth	-59.18%	-46.54%	-56.67%	-27.11%	-58.72%	389.47%
Accounts Receivable	0.2	0.24	0.23	0.5	0.42	0.71
Other Receivables	0.06	0.05	0.03	0.16	0.03	0.03
Total Trade Receivables	0.26	0.29	0.26	0.66	0.45	0.74
Inventory	1.5	1.62	2.27	3.73	2.95	3.34
Other Current Assets	0.08	0.09	0.1	0.11	0.52	0.06
Total Current Assets	2	2.35	3.27	6	5.96	9.09
Net Property, Plant & Equipment	4.47	4.57	4.92	7.22	10.01	13.41
Other Intangible Assets	38.67	24.08	6.7	3.26	1.81	0.15
Total Assets	45.14	31	14.89	16.47	17.78	22.65

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.84	0.89	0.23	0.97	0.67	0.93
Accrued Expenses	0.31	0.35	0.25	0.3	0.4	0.3
Short-Term Debt	1.47	1.44	1.14	2.07	6.28	2.78
Current Portion of Long-Term Debt	1.93	1.98	1.02	1.03	2.44	4.33
Current Portion of Leases	0.07	0.07	0.04	0.08	0.04	0.09
Unearned Revenue	0.06	0.11	0.16	0.09	0.52	0.21
Other Current Liabilities	2.59	2.56	2.18	2.28	2.39	1.88
Total Current Liabilities	7.27	7.4	5.02	6.82	12.74	10.51
Long-Term Debt	-	-	1.39	1.41	-	5.25
Long-Term Leases	0.09	0.11	-	0.04	-	0.04
Other Long-Term Liabilities	0.76	0.75	0.73	0.74	0.75	0.82
Total Long-Term Liabilities	0.85	0.86	2.12	2.19	0.75	6.12
Total Liabilities	8.12	8.26	7.14	9.01	13.49	16.63

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.04	0.02	0.03	0.01	0	0.05
Additional Paid-in Capital	73.32	58.36	40.42	35.28	28.93	25.65
Accumulated Other Comprehensive Income	12.02	11.58	11.32	11.45	11.57	12.56
Retained Earnings	-48.36	-47.21	-44.03	-39.29	-36.21	-32.24
Shareholders' Equity	37.02	22.74	7.75	7.45	4.29	6.02
Total Liabilities & Equity	45.14	31	14.89	16.47	17.78	22.65

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	3.56	3.6	3.59	4.63	8.76	12.49
Net Cash (Debt)	-3.39	-3.25	-2.95	-3.14	-6.71	-7.54
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.34	-0.76	-1.69	-9.29	-63.85	-81.70
Book Value	37.02	22.74	7.75	7.45	4.29	6.02
Book Value Per Share	3.75	5.30	4.44	22.03	40.80	65.23
Tangible Book Value	-1.65	-1.34	1.05	4.2	2.48	5.87
Tangible Book Value Per Share	-0.17	-0.31	0.60	12.41	23.61	63.63

SEC Filings: 10-K · 10-Q